Company profile: Cradle
1.1 - Company Overview
Company description
- Provider of a biotech machine-learning platform that uses prediction algorithms and AI design recommendations to assist biologists in designing proteins, offering complete IP ownership and maintaining the privacy and security of sequences and data.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Cradle
Deepcell
HQ: United States
Website
- Description: Provider of AI-powered single-cell classification and isolation solutions for basic and translational research, offering the REM-I platform combining high-resolution imaging, AI, and morphology-based sorting; the Human Foundation Model for real-time cell characterization; the Axon Data Suite for cloud storage, visualization, and analysis; plus advanced microfluidics and deep learning foundation models.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Deepcell company profile →
Alcedis
HQ: Germany
Website
- Description: Provider of digital clinical research services, including comprehensive trial management from phase I to approval, real-world evidence collection, and scientific consulting. Delivers platforms for multi-channel data integration with customized eCRFs, mobile applications, and big data interfaces, plus regulatory-compliant study design, technology integration to maximize data quality, and full study conduct.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Alcedis company profile →
Aparito
HQ: United Kingdom
Website
- Description: Provider of an eCOA platform (Atom5) that digitises clinical trials and captures real-world patient data via video assessments, ePROs, wearables, telemedicine, and eConsent, delivering real-time insights to clinical teams. Part 11, GDPR and HIPPA compliant, supporting patient-centric trials at scale in 193 countries and 125 languages.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Aparito company profile →
Envision Pharma
HQ: United States
Website
- Description: Provider of scientific communications and technology solutions for the life science industry, including iEnvision medical affairs and compliance software, medical affairs workflow tools, government pricing & analytics SaaS, strategic consulting for market launch and product acceleration, value & access services, and integrated support for medical communications, publication management, and digital engagement.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Envision Pharma company profile →
Cellarity
HQ: United States
Website
- Description: Provider of AI and single-cell omics–driven drug discovery solutions, including the Cellarity Platform to address cellular dysfunction across diseases; the Intervention Library to predict perturbation impacts on cell behaviors; the Cellarity Map to identify gene networks from health to disease; a drug discovery pipeline in hematology and immunology; and a MASH collaboration with Novo Nordisk.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Cellarity company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Cradle
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Cradle
2.2 - Growth funds investing in similar companies to Cradle
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Cradle
4.2 - Public trading comparable groups for Cradle
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →